Search research articles
Contact Us
Filters
Showing results (61-70 of 178) with videos related to
Page
of 18
Sort By:
Journal of Clinical Microbiology
|
July 1, 1994
Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay
M J Wolfhagen, A C Fluit, R Torensma, et al.
The Journal of Antimicrobial Chemotherapy
|
October 3, 2001
Induction of in vitro resistance to BMS-284756 by Streptococcus pneumoniae
F J Schmitz, M Boos, H Jagusch, et al.
Journal of Clinical Microbiology
|
November 1, 2002
mecA gene is widely disseminated in Staphylococcus aureus population
C L C Wielders, A C Fluit, S Brisse, et al.
FEMS Immunology and Medical Microbiology
|
November 27, 1999
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates
F J Schmitz, A C Fluit, S Brisse, et al.
The Journal of Antimicrobial Chemotherapy
|
December 11, 1999
Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin
F J Schmitz, R Sadurski, A Stattfeld, et al.
The Journal of Antimicrobial Chemotherapy
|
December 26, 2001
Characterization of the translational attenuator of 20 methicillin-resistant, quinupristin/dalfopristin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides
F J Schmitz, W Witte, G Werner, et al.
The Journal of Antimicrobial Chemotherapy
|
December 26, 2001
In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs
F-J Schmitz, M Boos, S Mayer, et al.
The Journal of Antimicrobial Chemotherapy
|
June 22, 2001
In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae
F J Schmitz, M Boos, S Mayer, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 1999
Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe
P Martinez-Freijo, A C Fluit, F J Schmitz, et al.
The Journal of Antimicrobial Chemotherapy
|
February 7, 2001
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates
F J Schmitz, A Krey, R Sadurski, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 178) with videos related to
Sort By:
Page
of 18
Journal of Clinical Microbiology
|
July 1, 1994
Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay
M J Wolfhagen, A C Fluit, R Torensma, et al.
The Journal of Antimicrobial Chemotherapy
|
October 3, 2001
Induction of in vitro resistance to BMS-284756 by Streptococcus pneumoniae
F J Schmitz, M Boos, H Jagusch, et al.
Journal of Clinical Microbiology
|
November 1, 2002
mecA gene is widely disseminated in Staphylococcus aureus population
C L C Wielders, A C Fluit, S Brisse, et al.
FEMS Immunology and Medical Microbiology
|
November 27, 1999
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates
F J Schmitz, A C Fluit, S Brisse, et al.
The Journal of Antimicrobial Chemotherapy
|
December 11, 1999
Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin
F J Schmitz, R Sadurski, A Stattfeld, et al.
The Journal of Antimicrobial Chemotherapy
|
December 26, 2001
Characterization of the translational attenuator of 20 methicillin-resistant, quinupristin/dalfopristin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides
F J Schmitz, W Witte, G Werner, et al.
The Journal of Antimicrobial Chemotherapy
|
December 26, 2001
In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs
F-J Schmitz, M Boos, S Mayer, et al.
The Journal of Antimicrobial Chemotherapy
|
June 22, 2001
In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae
F J Schmitz, M Boos, S Mayer, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 1999
Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe
P Martinez-Freijo, A C Fluit, F J Schmitz, et al.
The Journal of Antimicrobial Chemotherapy
|
February 7, 2001
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates
F J Schmitz, A Krey, R Sadurski, et al.
Page
of 18